QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Clinical trial NCT04326829 · UNKNOWN

Trial details

NCT number: NCT04326829
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2020-07-08
Primary completion: 2022-12-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.